Handelsinvest Investeringsforvaltning lifted its stake in shares of CryoPort Inc (NASDAQ:CYRX) by 100.0% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 20,000 shares of the consumer goods maker’s stock after buying an additional 10,000 shares during the quarter. Handelsinvest Investeringsforvaltning owned 0.06% of CryoPort worth $327,000 as of its most recent filing with the SEC.
Several other large investors also recently made changes to their positions in the stock. D. E. Shaw & Co. Inc. raised its holdings in shares of CryoPort by 1.6% during the 2nd quarter. D. E. Shaw & Co. Inc. now owns 48,429 shares of the consumer goods maker’s stock valued at $887,000 after buying an additional 783 shares during the period. Greenwood Capital Associates LLC increased its holdings in CryoPort by 5.8% during the 2nd quarter. Greenwood Capital Associates LLC now owns 20,014 shares of the consumer goods maker’s stock worth $367,000 after purchasing an additional 1,100 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in CryoPort by 2.2% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 64,566 shares of the consumer goods maker’s stock worth $1,183,000 after purchasing an additional 1,402 shares during the last quarter. Taylor Wealth Management Partners increased its holdings in CryoPort by 0.7% during the 2nd quarter. Taylor Wealth Management Partners now owns 299,830 shares of the consumer goods maker’s stock worth $5,493,000 after purchasing an additional 2,050 shares during the last quarter. Finally, Coastal Investment Advisors Inc. purchased a new stake in CryoPort during the 3rd quarter worth approximately $50,000. Institutional investors and hedge funds own 59.56% of the company’s stock.
Shares of NASDAQ CYRX traded up $0.38 during trading on Tuesday, reaching $14.78. The stock had a trading volume of 8,200 shares, compared to its average volume of 833,068. CryoPort Inc has a one year low of $8.28 and a one year high of $25.02. The company has a debt-to-equity ratio of 0.17, a quick ratio of 17.68 and a current ratio of 17.73. The stock has a market cap of $520.15 million, a PE ratio of -47.42 and a beta of 0.81. The firm’s 50 day moving average price is $16.74 and its two-hundred day moving average price is $17.73.
Several research firms have issued reports on CYRX. Svb Leerink restated an “outperform” rating on shares of CryoPort in a report on Monday, July 15th. B. Riley set a $26.00 price objective on CryoPort and gave the stock a “buy” rating in a report on Friday, July 19th. Needham & Company LLC began coverage on CryoPort in a report on Monday, July 1st. They set a “buy” rating and a $22.00 price objective on the stock. BidaskClub downgraded CryoPort from a “sell” rating to a “strong sell” rating in a report on Saturday, October 5th. Finally, ValuEngine downgraded CryoPort from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $24.00.
CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.
Featured Story: How is a buy-side analyst different from a sell-side analyst?
Want to see what other hedge funds are holding CYRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CryoPort Inc (NASDAQ:CYRX).
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.